vs
Quanex Building Products CORP（NX）とRevvity（RVTY）の財務データ比較。上の社名をクリックして会社を切り替えられます
Revvityの直近四半期売上が大きい（$772.1M vs $495.3M、Quanex Building Products CORPの約1.6倍）。Revvityの純利益率が高く（12.7% vs -55.7%、差は68.5%）。Quanex Building Products CORPの前年同期比売上増加率が高い（76.7% vs 5.9%）。Revvityの直近四半期フリーキャッシュフローが多い（$161.8M vs $46.2M）。過去8四半期でQuanex Building Products CORPの売上複合成長率が高い（29.5% vs 9.0%）
Quanex Building Products Corporationは、エンジニアリングされた建築部品・資材の大手製造企業です。主な製品には断熱ガラス用スペーサー、窓・ドアシステム、キ�ビネット・家具部品があり、北米・欧州の住宅・商業建築市場向けに省エネで持続可能な建築ソリューションを提供しています。
レブィティ（Revvity, Inc.）は米国のライフサイエンス・診断事業を手がける企業で、製薬およびバイオテクノロジー業界を主な顧客とし、特に新たな細胞治療や遺伝子治療の開発に関連するサービス・製品を提供している。前身は多岐にわたる事業を展開してきた老舗企業パーキンエルマーである。
NX vs RVTY — 直接比較
損益計算書 — Q3 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $495.3M | $772.1M |
| 純利益 | $-276.0M | $98.4M |
| 粗利率 | 27.9% | — |
| 営業利益率 | -54.7% | 14.5% |
| 純利益率 | -55.7% | 12.7% |
| 売上前年比 | 76.7% | 5.9% |
| 純利益前年比 | -1188.8% | 3.9% |
| EPS（希薄化後） | $-6.04 | $0.86 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | — | $772.1M | ||
| Q3 25 | $495.3M | $698.9M | ||
| Q2 25 | $452.5M | $720.3M | ||
| Q1 25 | $400.0M | $664.8M | ||
| Q4 24 | $492.2M | $729.4M | ||
| Q3 24 | $280.3M | $684.0M | ||
| Q2 24 | $266.2M | $691.7M | ||
| Q1 24 | $239.2M | $649.9M |
| Q4 25 | — | $98.4M | ||
| Q3 25 | $-276.0M | $46.7M | ||
| Q2 25 | $20.5M | $53.9M | ||
| Q1 25 | $-14.9M | $42.2M | ||
| Q4 24 | $-13.9M | $94.6M | ||
| Q3 24 | $25.4M | $94.4M | ||
| Q2 24 | $15.4M | $55.4M | ||
| Q1 24 | $6.2M | $26.0M |
| Q4 25 | — | — | ||
| Q3 25 | 27.9% | 53.6% | ||
| Q2 25 | 29.0% | 54.5% | ||
| Q1 25 | 23.1% | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.3% | 56.3% | ||
| Q2 24 | 24.9% | 55.7% | ||
| Q1 24 | 21.5% | 54.6% |
| Q4 25 | — | 14.5% | ||
| Q3 25 | -54.7% | 11.7% | ||
| Q2 25 | 9.0% | 12.6% | ||
| Q1 25 | -1.7% | 10.9% | ||
| Q4 24 | 0.6% | 16.3% | ||
| Q3 24 | 8.4% | 14.3% | ||
| Q2 24 | 7.8% | 12.4% | ||
| Q1 24 | 3.3% | 6.8% |
| Q4 25 | — | 12.7% | ||
| Q3 25 | -55.7% | 6.7% | ||
| Q2 25 | 4.5% | 7.5% | ||
| Q1 25 | -3.7% | 6.4% | ||
| Q4 24 | -2.8% | 13.0% | ||
| Q3 24 | 9.0% | 13.8% | ||
| Q2 24 | 5.8% | 8.0% | ||
| Q1 24 | 2.6% | 4.0% |
| Q4 25 | — | $0.86 | ||
| Q3 25 | $-6.04 | $0.40 | ||
| Q2 25 | $0.44 | $0.46 | ||
| Q1 25 | $-0.32 | $0.35 | ||
| Q4 24 | $-0.52 | $0.77 | ||
| Q3 24 | $0.77 | $0.77 | ||
| Q2 24 | $0.46 | $0.45 | ||
| Q1 24 | $0.19 | $0.21 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $66.3M | $919.9M |
| 総負債低いほど良い | $695.6M | — |
| 株主資本純資産 | $717.4M | $7.3B |
| 総資産 | $2.0B | $12.2B |
| 負債/資本比率低いほどレバレッジが低い | 0.97× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | — | $919.9M | ||
| Q3 25 | $66.3M | $931.4M | ||
| Q2 25 | $62.6M | $991.8M | ||
| Q1 25 | $50.0M | $1.1B | ||
| Q4 24 | $97.7M | $1.2B | ||
| Q3 24 | $94.0M | $1.2B | ||
| Q2 24 | $56.1M | $2.0B | ||
| Q1 24 | $44.4M | $1.7B |
| Q4 25 | — | — | ||
| Q3 25 | $695.6M | — | ||
| Q2 25 | $746.4M | — | ||
| Q1 25 | $725.2M | — | ||
| Q4 24 | $737.2M | — | ||
| Q3 24 | $51.4M | — | ||
| Q2 24 | $51.5M | — | ||
| Q1 24 | $61.6M | — |
| Q4 25 | — | $7.3B | ||
| Q3 25 | $717.4M | $7.4B | ||
| Q2 25 | $1.0B | $7.6B | ||
| Q1 25 | $972.1M | $7.6B | ||
| Q4 24 | $1.0B | $7.7B | ||
| Q3 24 | $594.1M | $7.9B | ||
| Q2 24 | $566.1M | $7.9B | ||
| Q1 24 | $555.0M | $7.8B |
| Q4 25 | — | $12.2B | ||
| Q3 25 | $2.0B | $12.1B | ||
| Q2 25 | $2.3B | $12.4B | ||
| Q1 25 | $2.2B | $12.4B | ||
| Q4 24 | $2.3B | $12.4B | ||
| Q3 24 | $872.5M | $12.8B | ||
| Q2 24 | $837.2M | $13.4B | ||
| Q1 24 | $813.4M | $13.4B |
| Q4 25 | — | — | ||
| Q3 25 | 0.97× | — | ||
| Q2 25 | 0.75× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.73× | — | ||
| Q3 24 | 0.09× | — | ||
| Q2 24 | 0.09× | — | ||
| Q1 24 | 0.11× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $60.7M | $182.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $46.2M | $161.8M |
| FCFマージンFCF / 売上 | 9.3% | 21.0% |
| 設備投資強度設備投資 / 売上 | 2.9% | 2.6% |
| キャッシュ転換率営業CF / 純利益 | — | 1.85× |
| 直近12ヶ月FCF直近4四半期 | $27.5M | $509.4M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | — | $182.0M | ||
| Q3 25 | $60.7M | $138.5M | ||
| Q2 25 | $28.5M | $134.3M | ||
| Q1 25 | $-12.5M | $128.2M | ||
| Q4 24 | $5.5M | $174.2M | ||
| Q3 24 | $46.4M | $147.9M | ||
| Q2 24 | $33.1M | $158.6M | ||
| Q1 24 | $3.9M | $147.6M |
| Q4 25 | — | $161.8M | ||
| Q3 25 | $46.2M | $120.0M | ||
| Q2 25 | $13.6M | $115.5M | ||
| Q1 25 | $-24.1M | $112.2M | ||
| Q4 24 | $-8.2M | $149.8M | ||
| Q3 24 | $40.1M | $125.6M | ||
| Q2 24 | $25.5M | $136.6M | ||
| Q1 24 | $-5.7M | $129.7M |
| Q4 25 | — | 21.0% | ||
| Q3 25 | 9.3% | 17.2% | ||
| Q2 25 | 3.0% | 16.0% | ||
| Q1 25 | -6.0% | 16.9% | ||
| Q4 24 | -1.7% | 20.5% | ||
| Q3 24 | 14.3% | 18.4% | ||
| Q2 24 | 9.6% | 19.7% | ||
| Q1 24 | -2.4% | 20.0% |
| Q4 25 | — | 2.6% | ||
| Q3 25 | 2.9% | 2.6% | ||
| Q2 25 | 3.3% | 2.6% | ||
| Q1 25 | 2.9% | 2.4% | ||
| Q4 24 | 2.8% | 3.4% | ||
| Q3 24 | 2.2% | 3.3% | ||
| Q2 24 | 2.9% | 3.2% | ||
| Q1 24 | 4.0% | 2.7% |
| Q4 25 | — | 1.85× | ||
| Q3 25 | — | 2.97× | ||
| Q2 25 | 1.39× | 2.49× | ||
| Q1 25 | — | 3.03× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | 1.83× | 1.57× | ||
| Q2 24 | 2.15× | 2.87× | ||
| Q1 24 | 0.62× | 5.67× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
NX
| Window And Door Hardware | $150.3M | 30% |
| Screens | $76.8M | 16% |
| Window Profiles | $68.2M | 14% |
| Spacers | $54.7M | 11% |
| Wood Solutions | $53.4M | 11% |
| Seals And Gaskets | $29.9M | 6% |
| Access Solutions | $27.4M | 6% |
| Mixing Solution | $21.5M | 4% |
| Solar | $5.3M | 1% |
| Product Type Other | $3.3M | 1% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
